MEGAN MICALETTI: Open Payments
NPI 1235782558 · KNOXVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,096 in 55 payments from 15 companies in 2025. Trend: 2023 $1,035 · 2024 $950 · 2025 $1,096
Food & beverage: $1,051Education: $45
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 25 | $490 |
| Novo Nordisk Inc | 4 | $94 |
| Vanda Pharmaceuticals Inc. | 3 | $88 |
| Lilly USA, LLC | 2 | $63 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $52 |
| ABBVIE INC. | 3 | $51 |
| Phathom Pharmaceuticals, Inc. | 3 | $49 |
| Xeris Pharmaceuticals, Inc. | 2 | $39 |
| GlaxoSmithKline, LLC. | 2 | $39 |
| PFIZER INC. | 2 | $37 |
Products named: AIRSUPRA, BREZTRI, FARXIGA, Ozempic, FANAPT, CAPLYTA, VOQUEZNA, GVOKE HYPOPEN.
Industry payments across TN — which companies pay providers there.
